Pellegrino, Benedetta http://orcid.org/0000-0001-9353-7445
Hlavata, Zuzana
Migali, Cristina
De Silva, Pushpamali
Aiello, Marco
Willard-Gallo, Karen
Musolino, Antonino
Solinas, Cinzia
Funding for this research was provided by:
Università degli Studi di Parma
Article History
Accepted: 12 April 2021
First Online: 11 May 2021
Declarations
:
: Open access funding provided by Università degli Studi di Parma within the CRUI-CARE Agreement. B.P. was supported by ESMO with a Clinical Translational Fellowship aid supported by Roche. Any views, opinions, findings, conclusions, or recommendations expressed in this material are those solely of the authors and do not necessarily reflect those of ESMO or Roche.
: CM: The opinions expressed in this article are the personal views of the author and may not be understood or quoted as being made on behalf of or reflecting the position of the Italian Medicines Agency (AIFA). AM: Reports grants and personal fees from Roche, personal fees from Lilly, grants from Eisai, personal fees from Novartis, personal fees from Macrogenics, outside the submitted work. BP, ZH, PDS, MA, KWG, and CS have no conflicts of interest to declare.
: Not applicable.
: NA.
: NA.
: All the authors substantially contributed to the conception of the work. BP, ZH, PDS, CM, and CS drafted the work and all the authors revised it critically for important intellectual content. All the authors finally approved the version published.